IBio Profit Margin 1970-1969 | IBIO
Current and historical gross margin, operating margin and net profit margin for IBio (IBIO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. IBio net profit margin as of December 31, 1969 is -895.37%.
|IBio Annual Profit Margins
|IBio Quarterly Profit Margins
||Medical - Biomedical and Genetics
Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. The Company's hydroponically grown green plants can be used for the development and manufacture of proteins applicable to a range of disease agents, such as influenza, sleeping sickness, anthrax, plague, human papillomavirus and veterinary influenza applications. IBio, Inc. is headquartered in Newark, Delaware.